Disrupting Protein-Protein Interactions With Bis-peptides
用双肽破坏蛋白质-蛋白质相互作用
基本信息
- 批准号:8442385
- 负责人:
- 金额:$ 29.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-01-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAmidesAmino AcidsAntibodiesApoptosisBedsBindingBinding ProteinsBiologicalBiological AssayBiologyC-terminalCell Culture TechniquesCell ProliferationCellsChargeChemistryCircular DichroismCollaborationsCollectionComplexDatabasesDevelopmentDipeptidesDiseaseEngineeringGoalsGrowthHepatitis B VirusHousingHumanHuman GenomeIn VitroLeadLengthLeucine ZippersLibrariesLigandsLocationMalignant NeoplasmsMalignant neoplasm of liverMeasurementMeasuresMethodologyModelingMolecularNaturePair BondPeptide ConformationPeptidesPharmaceutical ChemistryPharmaceutical PreparationsProtein BindingProteinsReactionRelative (related person)ReporterRoleSeriesShapesSideSpecific qualifier valueStructureSurfaceTertiary Protein StructureTestingTherapeuticUniversitiesVertebral columnVirtual LibraryWeightWestern Blottingc-myc Genescancer celldaltondesigndiketopiperazinedimerfunctional groupimprovedin vivointerestmacromoleculemdm2 proteinnovel therapeuticspancreatic secretory trypsin inhibitor Iprofessorprotein protein interactionpublic health relevancesmall moleculesoftware developmentstereochemistrytherapeutic proteinthree dimensional structuretissue/cell culturetool
项目摘要
DESCRIPTION (provided by applicant):
It has been estimated that 80% of the protein products of the human genome are "undruggable" because they either lack deep hydrophobic pockets that can bind small molecules or they are inside cells where antibodies and other biological drugs cannot reach them. A goal of my group is to develop molecules that can bind these undruggable proteins and penetrate cells to create new therapeutics and molecular tools to probe biology. We have developed a unique approach to the synthesis of chemically functionalized macromolecules with programmable shapes. We have developed the synthesis of a collection of chiral, cyclic building blocks that we connect through pairs of amide bonds to create complex and pre-organized spiro-ladder oligomers, called bis- peptides, between 500 and 2,000 Daltons in weight. We have recently discovered new chemistry that allows us to incorporate a functional group on every building block. We have developed this chemistry to the point where we can create highly functionalized macromolecules that can present proteogenic and non-proteogenic groups in any three- dimensional arrangement required. In terms of "diversity oriented synthesis" these oligomers have very diverse three-dimensional structures by virtue of their constrained nature and rich stereochemistry. We propose to use this synthetic methodology to create functionalized bis-peptides that will mimic short ?-helices to bind helix binding proteins; mimic long ?-helices to disrupt coiled-coils; and identify protein-protein interactions in the Brookhaven Protein Data Bank that can be targeted using these oligomers. In preliminary results we have demonstrated a functionalized bis-peptide that binds Mdm2 with higher affinity than the wild-type p53 peptide and is taken up by cells. We propose to develop functionalized bis-peptides that simultaneously bind Mdm2 and Mdmx and others that bind c-Myc and study their ability to enter and arrest growth in liver cancer cells.
描述(由申请人提供):
据估计,人类基因组中80%的蛋白质产品是无法下药的,因为它们要么缺乏能够结合小分子的深层疏水口袋,要么位于抗体和其他生物药物无法到达的细胞内。我的团队的一个目标是开发能够结合这些不可药物的蛋白质并穿透细胞的分子,以创造新的疗法和分子工具来探索生物学。我们开发了一种独特的方法来合成具有可编程形状的化学功能化大分子。我们已经开发了一系列手性、环状构建块的合成,我们通过酰胺键对将这些构建块连接起来,以创建复杂的预先组织的螺旋梯形低聚物,称为双肽,重量在500至2000道尔顿之间。我们最近发现了一种新的化学方法,它允许我们在每一块积木上加入一个官能团。我们已经将这种化学发展到了可以创造高度功能化的大分子的地步,这些大分子可以以任何所需的三维排列来呈现蛋白生成和非蛋白生成基团。在“多样性导向合成”方面,这些低聚物凭借其受约束的性质和丰富的立体化学,具有非常多样化的三维结构。我们建议使用这种合成方法来创建功能化的双肽,它将模拟短?螺旋来结合螺旋结合蛋白;模拟长?螺旋来破坏螺旋卷曲;并在布鲁克海文蛋白质数据库中识别可以使用这些寡聚体来靶向的蛋白质-蛋白质相互作用。在初步结果中,我们已经证明了一种功能化的双肽,它与MDM2结合的亲和力比野生型P53肽更高,并被细胞摄取。我们建议开发同时结合MDM2和MDMX以及其他结合c-Myc的功能化双肽,并研究它们进入和阻止肝癌细胞生长的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christian E Schafmeister其他文献
Molecular lego.
- DOI:
10.1038/scientificamerican0207-76 - 发表时间:
2007 - 期刊:
- 影响因子:3
- 作者:
Christian E Schafmeister - 通讯作者:
Christian E Schafmeister
Christian E Schafmeister的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christian E Schafmeister', 18)}}的其他基金
Development of Protein Surface Binding, Low Entropy Oligomers
蛋白质表面结合、低熵寡聚物的开发
- 批准号:
8538457 - 财政年份:2010
- 资助金额:
$ 29.53万 - 项目类别:
Development of Protein Surface Binding, Low Entropy Oligomers
蛋白质表面结合、低熵寡聚物的开发
- 批准号:
7994521 - 财政年份:2010
- 资助金额:
$ 29.53万 - 项目类别:
Development of Protein Surface Binding, Low Entropy Oligomers
蛋白质表面结合、低熵寡聚物的开发
- 批准号:
8133995 - 财政年份:2010
- 资助金额:
$ 29.53万 - 项目类别:
Development of Protein Surface Binding, Low Entropy Oligomers
蛋白质表面结合、低熵寡聚物的开发
- 批准号:
8328741 - 财政年份:2010
- 资助金额:
$ 29.53万 - 项目类别:
Synthesis and Applications of functional Macromolecules
功能高分子的合成及应用
- 批准号:
6837203 - 财政年份:2004
- 资助金额:
$ 29.53万 - 项目类别:
Synthesis and Applications of functional Macromolecules
功能高分子的合成及应用
- 批准号:
7169205 - 财政年份:2004
- 资助金额:
$ 29.53万 - 项目类别:
Disrupting Protein-Protein Interactions With Bis-peptides
用双肽破坏蛋白质-蛋白质相互作用
- 批准号:
8214581 - 财政年份:2004
- 资助金额:
$ 29.53万 - 项目类别:
Disrupting Protein-Protein Interactions With Bis-peptides
用双肽破坏蛋白质-蛋白质相互作用
- 批准号:
8041596 - 财政年份:2004
- 资助金额:
$ 29.53万 - 项目类别:
Synthesis and Applications of functional Macromolecules
功能高分子的合成及应用
- 批准号:
7336332 - 财政年份:2004
- 资助金额:
$ 29.53万 - 项目类别:
Disrupting Protein-Protein Interactions With Bis-peptides
用双肽破坏蛋白质-蛋白质相互作用
- 批准号:
8606215 - 财政年份:2004
- 资助金额:
$ 29.53万 - 项目类别:
相似海外基金
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
- 批准号:
2140205 - 财政年份:2022
- 资助金额:
$ 29.53万 - 项目类别:
Standard Grant
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
- 批准号:
2140196 - 财政年份:2022
- 资助金额:
$ 29.53万 - 项目类别:
Standard Grant
Atroposelective Synthesis of Hindered Amides - Exploration of Synthetic Peptide Catalysts -
受阻酰胺的天体选择性合成-合成肽催化剂的探索-
- 批准号:
504378162 - 财政年份:2022
- 资助金额:
$ 29.53万 - 项目类别:
WBP Fellowship
Development of Peptide Chemical Modification Enabled by N-Halogenation of Amides
酰胺 N-卤化实现的肽化学修饰的发展
- 批准号:
22H02743 - 财政年份:2022
- 资助金额:
$ 29.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
- 批准号:
10532252 - 财政年份:2021
- 资助金额:
$ 29.53万 - 项目类别:
CAREER: SusChEM: Iron Catalysts for the Reduction of Amides
职业:SusChEM:用于还原酰胺的铁催化剂
- 批准号:
2146728 - 财政年份:2021
- 资助金额:
$ 29.53万 - 项目类别:
Continuing Grant
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
- 批准号:
10399712 - 财政年份:2021
- 资助金额:
$ 29.53万 - 项目类别:
Nickel-Catalyzed Alpha-Arylation of Secondary Amides
镍催化仲酰胺的α-芳基化
- 批准号:
558383-2020 - 财政年份:2020
- 资助金额:
$ 29.53万 - 项目类别:
Canadian Graduate Scholarships Foreign Study Supplements
Function of primary fatty acid amides as lipid mediators
伯脂肪酸酰胺作为脂质介质的功能
- 批准号:
20K21285 - 财政年份:2020
- 资助金额:
$ 29.53万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Improving selectivity in Ni-catalyzed activation of amides
提高镍催化酰胺活化的选择性
- 批准号:
518319-2018 - 财政年份:2020
- 资助金额:
$ 29.53万 - 项目类别:
Postgraduate Scholarships - Doctoral














{{item.name}}会员




